Go to deals
Healthcare

Empirical Bioscience has been acquired by Fortis Life Sciences

The owner of Empirical Bioscience has sold the company to Fortis Life Sciences.

Empirical Bioscience is a leading developer and manufacturer of enzymes, proteins and reagents for molecular biology and life science applications. Empirical focuses on supplying premium, quality and custom-configured products to the life sciences industry for both research and commercial applications. The company has a comprehensive library of products that can be readily configured to customer specifications and offers technical support to assist with the development and launch of assays and products.

Fortis Life Sciences is a strategic platform providing capital, expertise and operational resources enabling the growth and success of founder-led life science tools companies.

One of Oaklins’ teams in the USA served as the financial advisor to Empirical Bioscience in its sale to Fortis Life Sciences.

Service
M&A sell-side
Parties

Talk to the deal team

 Bradford A. Adams

Bradford A. Adams

Managing Director

Boston, United States
Oaklins TM Capital
 Michael S. Goldman

Michael S. Goldman

Managing Director

New York, United States
Oaklins TM Capital
 Harrison P. Boeschenstein

Harrison P. Boeschenstein

Analyst

Boston, United States
Oaklins TM Capital

Related deals

SulAmérica and Rede D’Or São Luiz have announced a combination
Financial Services | Healthcare

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Learn more
Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes
Private Equity | Healthcare

Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes

Groupe Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes from the funding family.

Learn more
Biosynex has acquired Para’kito
Healthcare

Biosynex has acquired Para’kito

Biosynex has acquired Para’kito, operated by Hong-Kong based Evergreen Land Ltd. The transaction includes assets and IP and the exclusive right to commercialize the brand in Europe, Africa and South America.

Learn more